Grifols Biologicals

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:Grifols_S._A.
gptkbp:accessories Forms supply partnerships with hospitals
gptkbp:acquisition gptkb:Biotest_AG
gptkb:Talecris_Biotherapeutics
gptkbp:advocates_for Engages in patient advocacy efforts
gptkbp:awards Received multiple industry awards
gptkbp:ceo Victor Grifols
gptkbp:clinical_trial Conducts clinical trials for new therapies
Participates in international clinical trials
Conducts clinical research in immunology
gptkbp:collaborations Collaborates with research institutions
gptkbp:community_engagement Supports local communities
gptkbp:distribution Distributes products globally
gptkbp:economic_impact Expanding into emerging markets
gptkbp:employees over 24,000
gptkbp:focus Blood plasma collection
gptkbp:founded gptkb:1940
gptkbp:founder gptkb:Victor_Grifols_Roura
gptkbp:global_presence Strong global presence in healthcare
gptkbp:headquarters gptkb:Barcelona,_Spain
gptkbp:healthcare Contributes to global health initiatives
https://www.w3.org/2000/01/rdf-schema#label Grifols Biologicals
gptkbp:industry Pharmaceuticals
Utilizes biomanufacturing processes
gptkbp:innovation Focuses on product innovation in therapies.
Innovates in plasma fractionation technology
gptkbp:investment Invests in new technologies
gptkbp:leadership Leads in the plasma-derived therapies market
gptkbp:market Significant market share in plasma products
gptkbp:operates_in over 30 countries
gptkbp:partnership gptkb:charity
Partnerships with universities
Collaborates with healthcare providers
gptkbp:philanthropy Engages in philanthropic activities
gptkbp:product_line Factor VIII
Albumin
Hyperimmune globulins
IVIG (Intravenous Immunoglobulin)
SCIG (Subcutaneous Immunoglobulin)
gptkbp:products Plasma-derived medicines
Emphasizes quality control in production
Focuses on product development for rare diseases
gptkbp:provides_information_on Develops clinical guidelines for treatment
gptkbp:regulatory_compliance Complies with FDA regulations
Complies with EMA regulations
Has a dedicated regulatory affairs team
gptkbp:research Invests in biotechnology research
gptkbp:research_and_development Invests heavily in R& D
gptkbp:revenue €5.3 billion (2020)
gptkbp:safety_features Ensures product safety and efficacy
gptkbp:scholarships Provides patient support programs
gptkbp:social_responsibility Strong commitment to CSR
gptkbp:stock_exchange gptkb:NASDAQ
gptkbp:subsidiary gptkb:Grifols_Diagnostic_Solutions
gptkbp:supply_chain Maintains a robust supply chain
Implements effective supply chain management
gptkbp:sustainability_initiatives Focuses on sustainability in operations
gptkbp:training Offers extensive employee training programs
Provides clinical education for healthcare professionals
gptkbp:website www.grifols.com